These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 30553470

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
    Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC.
    Clin Cancer Res; 2009 Sep 01; 15(17):5494-502. PubMed ID: 19706817
    [Abstract] [Full Text] [Related]

  • 65. Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
    Dunleavy K.
    Curr Treat Options Oncol; 2015 Dec 01; 16(12):58. PubMed ID: 26634708
    [Abstract] [Full Text] [Related]

  • 66. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E, Tan LH, Tay K, Lim ST, Tang T, Lee YY, Tan SY.
    Histopathology; 2012 Dec 01; 61(6):1214-8. PubMed ID: 23171357
    [Abstract] [Full Text] [Related]

  • 67. Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
    Lucioni M, Pescia C, Bonometti A, Fraticelli S, Moltrasio C, Ramponi A, Riboni R, Roccio S, Ferrario G, Arcaini L, Goteri G, Berti E, Paulli M.
    Hum Pathol; 2021 May 01; 111():1-9. PubMed ID: 33548250
    [Abstract] [Full Text] [Related]

  • 68. Optimizing initial therapy in DLBCL.
    Thieblemont C, Bernard S, Meignan M, Molina T.
    Best Pract Res Clin Haematol; 2018 Sep 01; 31(3):199-208. PubMed ID: 30213389
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.
    Nowakowski GS, Blum KA, Kahl BS, Friedberg JW, Baizer L, Little RF, Maloney DG, Sehn LH, Williams ME, Wilson WH, Leonard JP, Smith SM.
    J Natl Cancer Inst; 2016 Dec 01; 108(12):. PubMed ID: 27986884
    [Abstract] [Full Text] [Related]

  • 71. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
    Li M, Liu CL, Wang XY, Xue XM, Gao ZF.
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec 01; 41(12):813-7. PubMed ID: 23324229
    [Abstract] [Full Text] [Related]

  • 72. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
    Durot E, Tomowiak C, Michallet AS, Dupuis J, Hivert B, Leprêtre S, Toussaint E, Godet S, Merabet F, Van Den Neste E, Ivanoff S, Roussel X, Zini JM, Regny C, Lemal R, Sutton L, Perrot A, Le Dû K, Kanagaratnam L, Morel P, Leblond V, Delmer A.
    Br J Haematol; 2017 Nov 01; 179(3):439-448. PubMed ID: 28770576
    [Abstract] [Full Text] [Related]

  • 73. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
    Gong QX, Wang Z, Liu C, Li X, Lu TX, Liang JH, Xu W, Li JY, Zhang ZH.
    J Clin Pathol; 2018 Sep 01; 71(9):795-801. PubMed ID: 29666157
    [Abstract] [Full Text] [Related]

  • 74. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
    Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S.
    Am J Surg Pathol; 2015 Sep 01; 39(9):1250-8. PubMed ID: 25828389
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.